(Q28350866)

English

Treatment of advanced neuroblastoma: feasibility and therapeutic potential of a novel approach combining 131-I-MIBG and multiple drug chemotherapy

scientific article

In more languages

Statements

scholarly article

0 references

Treatment of advanced neuroblastoma: feasibility and therapeutic potential of a novel approach combining 131-I-MIBG and multiple drug chemotherapy (English)

0 references

0 references

1 reference

based on heuristic

inferred from title

author name string

S Mastrangelo

1

0 references

A Tornesello

2

0 references

L Diociaiuti

3

0 references

A Pession

4

0 references

A Prete

5

0 references

V Rufini

6

0 references

L Troncone

7

0 references

R Mastrangelo

8

0 references

language of work or name

0 references

publication date

February 2001

0 references

British Journal of Cancer

0 references

84

0 references

4

0 references

460-4

0 references

Treatment of high-risk neuroblastoma with intensive chemotherapy, radiotherapy, autologous bone marrow transplantation, and 13-cis-retinoic acid. Children's Cancer Group

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2363758

29 September 2017

Phase I dose escalation of 131I-metaiodobenzylguanidine with autologous bone marrow support in refractory neuroblastoma

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2363758

29 September 2017

The effect of cisplatin pretreatment on the accumulation of MIBG by neuroblastoma cells in vitro

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2363758

29 September 2017

Critical observations on neuroblastoma treatment with 131-I-metaiodobenzylguanidine at diagnosis

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2363758

29 September 2017

Revisions of the international criteria for neuroblastoma diagnosis, staging, and response to treatment.

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2363758

29 September 2017

First line targeted radiotherapy, a new concept in the treatment of advanced stage neuroblastoma

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2363758

29 September 2017

Short duration, high dose, alternating chemotherapy in metastatic neuroblastoma. (ENSG 3C induction regimen). The European Neuroblastoma Study Group

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2363758

29 September 2017

Cyclophosphamide 24 hours before or after total body irradiation: effects on lung and bone marrow

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2363758

29 September 2017

Phase I/II study of iodine 131 metaiodobenzylguanidine in chemoresistant neuroblastoma: a United Kingdom Children's Cancer Study Group investigation

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2363758

29 September 2017

A new approach in the treatment of stage IV neuroblastoma using a combination of [131I]meta-iodobenzylguanidine (MIBG) and cisplatin.

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2363758

2 June 2018

Radiolabeled adrenergi neuron-blocking agents: adrenomedullary imaging with [131I]iodobenzylguanidine

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2363758

2 June 2018

Iodine-131 metaiodobenzylguanidine scintigraphy for the location of neuroblastoma: preliminary experience in ten cases.

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2363758

2 June 2018

A phase II study of high-dose cisplatin and VP-16 in neuroblastoma: a report from the Société Française d'Oncologie Pédiatrique

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2363758

2 June 2018

Enhanced post-irradiation recovery of the haemopoietic system in animals pretreated with a variety of cytotoxic agents

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2363758

2 June 2018

Optimal use of the 131-I-metaiodobenzylguanidine and cisplatin combination in advanced neuroblastoma

1 reference

https://pubmed.ncbi.nlm.nih.gov/11207038

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Sparing effect of cyclophosphamide (NSC-26271) pretreatment on animals lethally treated with gamma-irradiation

1 reference

https://pubmed.ncbi.nlm.nih.gov/11207038

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

The treatment of neuroblastoma

1 reference

https://pubmed.ncbi.nlm.nih.gov/11207038

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

The treatment of neuroblastoma with 131I-MIBG

1 reference

https://pubmed.ncbi.nlm.nih.gov/11207038

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Treatment of neuroblastoma with 131I-MIBG: dosimetric problems and perspectives

1 reference

https://pubmed.ncbi.nlm.nih.gov/11207038

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

131I-metaiodobenzylguanidine in the treatment of neuroblastoma at diagnosis

1 reference

https://pubmed.ncbi.nlm.nih.gov/11207038

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Session on the treatment of neuroblastoma with radioiodinated metaiodobenzylguanidine. Chairmen's report

1 reference

https://pubmed.ncbi.nlm.nih.gov/11207038

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Etoposide and carboplatin in neuroblastoma: a French Society of Pediatric Oncology phase II study

1 reference

https://pubmed.ncbi.nlm.nih.gov/11207038

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Identifiers

10.1054/BJOC.2000.1645

0 references

Dimensions Publication ID

0 references

PMC publication ID

0 references

PubMed publication ID

0 references

ResearchGate publication ID

0 references

Sitelinks

Wikipedia(0 entries)

Wikibooks(0 entries)

Wikinews(0 entries)

Wikiquote(0 entries)

Wikisource(0 entries)

Wikiversity(0 entries)

Wikivoyage(0 entries)

Wiktionary(0 entries)

Multilingual sites(0 entries)

Retrieved from "https://www.wikidata.org/w/index.php?title=Q28350866&oldid=2175246861"